MedTrace Logo

Safety and Tolerability of 2 Dietary Supplement Beverages Designed to Maintain Healthy Blood Pressure.

NCT06442293 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-06-04

No results posted yet for this study

Summary

This study is designed to evaluate the safety and tolerability of two distinct dietary supplement beverage formulations designed to maintain normal blood pressure. In this study, safety and tolerability will be assessed among otherwise healthy, normotensive individuals.

Conditions

  • Safety Issues
  • Tolerance

Interventions

DIETARY_SUPPLEMENT

Treatment 1

A dietary supplement containing beet root extract, arginine and citrulline

DIETARY_SUPPLEMENT

Treatment 2

A traditional Chinese medicine (TCM)-based dietary supplement containing chrysanthemum extract and eucommia bark extract

DIETARY_SUPPLEMENT

Placebo

a placebo supplement that is similar in appearance to treatment 1

Sponsors & Collaborators

  • USANA Health Sciences

    lead INDUSTRY

Principal Investigators

  • Mark Levy, PhD · USANA Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2024-08-15
Completion
2024-08-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06442293 on ClinicalTrials.gov